| Mean length of stay (in days) | Odds of recovery | ||||
---|---|---|---|---|---|---|
 | Point | (95% CI) | p-value | OR | (95% CI) | p-value |
Unadjusted model | Â | Â | Â | Â | Â | Â |
 Protocol type |  |  |  |  |  |  |
 Full standard protocol | Reference group |  | Reference group |  | ||
 Partially adapted: admission only | − 9.96 | (− 10.91–9.01) |  < 0.001 | 0.87 | (0.77–0.97) | 0.014 |
 Partially adapted: admission + dosing | − 6.86 | (− 7.89–5.82) |  < 0.001 | 2.89 | (2.41–3.47) |  < 0.001 |
 Full adapted protocol | − 10.86 | (− 12.26–9.46) |  < 0.001 | 4.02 | (3.06–5.28) |  < 0.001 |
Adjusted modela | Â | Â | Â | Â | Â | Â |
 Protocol type |  |  |  |  |  |  |
 Full standard protocol | Reference group |  | Reference group |  | ||
 Partially adapted: admission only | − 28.35 | (− 30.18–26.51) |  < 0.001 | 2.56 | (2.18–3.01) |  < 0.001 |
 Partially adapted: admission + dosing | − 5.09 | (− 6.15–4.03) |  < 0.001 | 1.78 | (1.45–2.19) |  < 0.001 |
 Full adapted protocol | − 3.01 | (− 5.05–0.98) | 0.004 | 2.41 | (1.69–3.45) |  < 0.001 |
 Age (months) | − 0.02 | (− 0.06–0.02) | 0.294 | 1.00 | (1.00–1.01) | 0.406 |
 Female sex | − 0.15 | (− 0.90–0.61) | 0.701 | 1.12 | (1.00–1.26) | 0.042 |
 MUAC at admission (in mm) | − 0.77 | (− 0.87–0.67) |  < 0.001 | 1.14 | (1.13–1.15) |  < 0.001 |
 ICC (NGO) | 0.1553 | 0.1143 | ||||
 N | 13,451 | 14,774 |